The Majority Of Oncologists Will Begin Using Biosimilar Monoclonal Antibodies ... PR Newswire (press release) EXTON, Pa., Oct. 31, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed U.S. and European oncologists will cautiously adopt biosimilar ... |
